Serum Matrix Metalloproteinase-2 Levels Indicate Blood–CSF Barrier Damage in Patients with Infectious Meningitis

The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism

1973 • 1,062 citations

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

1977 • 867 citations

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

1977 • 779 citations

Molecular insights into cancer invasion: strategies for prevention and intervention.

1995 • 500 citations

Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.

2006 • 287 citations

Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid

1977 • 181 citations

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes

2003 • 175 citations

Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid

1977 • 169 citations

Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of alzheimer type and multi-infarct dementia

1983 • 121 citations

Isolated blood–cerebrospinal fluid barrier dysfunction: prevalence and associated diseases

2005 • 101 citations

Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis

1998 • 95 citations

Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis

2000 • 80 citations

Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: Correlation with metastatic behavior in vivo

1997 • 53 citations

Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer.

2002 • 38 citations

Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy

2006 • 37 citations

The ?2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier

1974 • 35 citations

Levels of interleukin‐6, CRP and α2 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood‐ CSF barrier damage

1997 • 28 citations

Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer.

2001 • 27 citations

Laser nephelometric evaluation of albumin, IgG and α2-macroglobulin: applications to the study of alterations of the blood-brain barrier

1993 • 26 citations

Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients

1984 • 23 citations

Gelatinases [Matrix Metalloproteinase-2 (MMP-2) and MMP-9] Induce Carotid Plaque Instability But Their Systemic Levels Are Not Predictive of Local Events

2005 • 21 citations

Progression of prostate cancer: Diagnostic and prognostic utility of prostate-specific antigen, α2-macroglobulin, and their complexes

2001 • 12 citations

Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting

2007 • 4 citations

Protein abnormalities in CSF and blood under blood-cerebrospinal fluid barrier damage.

1996 • 2 citations